(Total Views: 634)
Posted On: 05/08/2022 10:08:22 PM
Post# of 145879
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
We get a mention...
"Only one Long Haulers study using an investigational drug was completed—a trial for Long-COVID patients testing the monoclonal antibody, leronlimab, sponsored by Cytodyn (CYDY). Surprisingly, the results of the Long Covid trial were quite good and showed a clinically significant improvement in 18 out of 24 symptoms measured back in June 2021. There were reports that the company was waiting for FDA guidance regarding an approvable endpoint. "
https://www.zerohedge.com/news/2022-05-08/pfi...long-covid
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)